NCT03313804View on ClinicalTrials.gov

Priming Immunotherapy in Advanced Disease With Radiation

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

February 16, 2024

Study Completion Date

January 31, 2026

Conditions
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

Immune checkpoint inhibitor

Standard of care immune checkpoint inhibitor

RADIATION

Radiation Therapy

Stereotactic Body Radiation Therapy OR Fractionated radiation therapy

Trial Locations (1)

40536

University of Kentucky Markey Cancer Center, Lexington

All Listed Sponsors
lead

John L. Villano, MD, PhD

OTHER